Published in Immunol Lett on June 26, 2010
Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity (2012) 2.58
IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells. PLoS One (2010) 0.96
The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. Immunology (2013) 0.95
Decreased miR-26a expression correlates with the progression of podocyte injury in autoimmune glomerulonephritis. PLoS One (2014) 0.95
Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1. PLoS One (2012) 0.80
Internal standard-based analysis of microarray data2--analysis of functional associations between HVE-genes. Nucleic Acids Res (2011) 0.79
IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation. J Immunol Res (2015) 0.76
Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76
The p53 pathway: positive and negative feedback loops. Oncogene (2005) 9.75
Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol (2005) 7.74
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med (1999) 7.41
HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science (2009) 6.59
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
Decision making by p53: life, death and cancer. Cell Death Differ (2003) 5.52
Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity (2006) 5.47
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature (2003) 4.80
Systemic lupus erythematosus. Cell (1996) 4.21
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem (2001) 4.21
Role of NF-kappaB in p53-mediated programmed cell death. Nature (2000) 3.62
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med (2003) 3.50
Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity (2001) 3.18
Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma. Blood (1966) 2.51
In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol (2004) 2.50
Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell (2002) 2.48
Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med (2010) 2.35
Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. Immunity (2006) 2.33
Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol Lett (2008) 2.26
The HIN domain of IFI-200 proteins consists of two OB folds. Biochem Biophys Res Commun (2005) 2.25
Interferons as pathogenic effectors in autoimmunity. Immunol Rev (2005) 1.62
Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity (2002) 1.53
Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes (2005) 1.46
Interferon-inducible p200-family proteins as novel sensors of cytoplasmic DNA: role in inflammation and autoimmunity. J Interferon Cytokine Res (2010) 1.45
The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat Med (2000) 1.43
The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol (1996) 1.26
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells. J Biol Chem (2007) 1.23
The role of innate immunity in the induction of autoimmunity. Autoimmun Rev (2008) 1.21
Cytoplasmic p53: bax and forward. Cell Cycle (2004) 1.21
Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival. J Biol Chem (2005) 1.19
Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med (1997) 1.18
Interferon-inducible IFI16 protein in human cancers and autoimmune diseases. Front Biosci (2008) 1.17
Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest (2007) 1.14
Inhibition of B cell receptor-mediated apoptosis by IFN. J Immunol (1999) 1.12
Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene (2000) 1.12
Interferon action: cytoplasmic and nuclear localization of the interferon-inducible 52-kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J Interferon Res (1993) 1.11
Interferon-inducible p202 in the susceptibility to systemic lupus. Front Biosci (2002) 1.11
Structure and mechanism in NF-kappa B/I kappa B signaling. Cold Spring Harb Symp Quant Biol (1999) 1.09
IFI16 as a negative regulator in the regulation of p53 and p21(Waf1). J Biol Chem (2003) 1.08
Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol (2009) 1.07
Lupus and cancer. Lupus (2009) 1.07
Despite inhibition of nuclear localization of NF-kappa B p65, c-Rel, and RelB, 17-beta estradiol up-regulates NF-kappa B signaling in mouse splenocytes: the potential role of Bcl-3. J Immunol (2007) 1.06
The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression. J Biol Chem (2001) 1.05
p53 in the cytoplasm: a question of overkill? Cell (2004) 1.05
Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology (2008) 1.01
NF-kB inhibitor blocks B cell development at two checkpoints. Med Immunol (2004) 1.00
Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol (2006) 1.00
Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster. Genomics (1999) 0.96
Immunology. Lymphocyte survival--ignorance is BLys. Science (2000) 0.96
p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death Differ (2009) 0.96
The interferon-inducible p202a protein modulates NF-kappaB activity by inhibiting the binding to DNA of p50/p65 heterodimers and p65 homodimers while enhancing the binding of p50 homodimers. J Biol Chem (2003) 0.94
Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev (2002) 0.93
Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53. Mol Cancer Res (2008) 0.93
Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol (2007) 0.92
Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice. J Exp Med (1974) 0.91
Cellular and molecular bases of B-cell clonal expansions. Clin Exp Rheumatol (1996) 0.87
Malignancy in systemic lupus erythematosus: what have we learned? Best Pract Res Clin Rheumatol (2009) 0.87
Subcellular localization and mechanisms of nucleocytoplasmic distribution of p202, an interferon-inducible candidate for lupus susceptibility. FEBS Lett (2003) 0.86
The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus. Lupus (2005) 0.85
Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells. Int Immunol (2007) 0.85
p53 is required for spontaneous autoantibody production in B6/lpr lupus mice. Eur J Immunol (2005) 0.83
Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity. Tumour Biol (2003) 0.82
Comment on "Development of murine lupus involves the combined genetic contribution of the SLAM and Fc gamma R intervals within the Nba2 autoimmune susceptibility locus". J Immunol (2010) 0.82
Effects of adenoviral wild-type p53 gene transfer in p53-mutated lymphoma cells. Cancer Gene Ther (2001) 0.81
TP53 gene mutation, an unfavorable prognostic factor for malignant lymphomas in autoimmune diseases. Oncology (2005) 0.79
The thousand doors that lead to death: p53-dependent repression and apoptosis. Cancer Biol Ther (2003) 0.79
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med (2003) 3.50
The HIN domain of IFI-200 proteins consists of two OB folds. Biochem Biophys Res Commun (2005) 2.25
DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett (2006) 1.62
Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence. Oncogene (2003) 1.23
p38 isoforms have opposite effects on AP-1-dependent transcription through regulation of c-Jun. The determinant roles of the isoforms in the p38 MAPK signal specificity. J Biol Chem (2002) 1.19
Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol Immunol (2011) 1.16
Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J Immunol (2010) 1.16
IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes. PLoS One (2011) 1.14
Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress. Neoplasia (2007) 1.11
Expression of androgen receptor is negatively regulated by p53. Neoplasia (2007) 1.08
Role of IFI 16 in cellular senescence of human fibroblasts. Oncogene (2004) 1.07
Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol (2009) 1.07
Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene (2002) 1.05
Differential roles for the interferon-inducible IFI16 and AIM2 innate immune sensors for cytosolic DNA in cellular senescence of human fibroblasts. Mol Cancer Res (2011) 1.03
Molecular mechanism for p202-mediated specific inhibition of AIM2 inflammasome activation. Cell Rep (2013) 1.02
Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J Mol Cell Biol (2010) 1.02
Interleukin-6 induces expression of Ifi202, an interferon-inducible candidate gene for lupus susceptibility. J Biol Chem (2004) 1.00
Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interferon Cytokine Res (2011) 1.00
Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis. J Immunol (2006) 1.00
Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein. FEBS Lett (2006) 0.96
IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells. PLoS One (2010) 0.96
Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity. Mol Immunol (2012) 0.95
AIM2, an IFN-inducible cytosolic DNA sensor, in the development of benign prostate hyperplasia and prostate cancer. Mol Cancer Res (2013) 0.94
Mutually positive regulatory feedback loop between interferons and estrogen receptor-alpha in mice: implications for sex bias in autoimmunity. PLoS One (2010) 0.93
Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53. Mol Cancer Res (2008) 0.93
IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway. PLoS One (2011) 0.92
Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice. J Immunol (2008) 0.90
Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility protein. J Immunol (2011) 0.89
Crosstalk between the peroxisome proliferator-activated receptor γ (PPARγ) and the vitamin D receptor (VDR) in human breast cancer cells: PPARγ binds to VDR and inhibits 1α,25-dihydroxyvitamin D3 mediated transactivation. Exp Cell Res (2012) 0.87
A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16. Neoplasia (2008) 0.87
Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene. PLoS One (2010) 0.87
Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Mol Immunol (2011) 0.86
IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway. Am J Physiol Lung Cell Mol Physiol (2003) 0.86
Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth. Oncogene (2003) 0.86
Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival. J Cell Biochem (2003) 0.86
Stimulation of T cells up-regulates expression of Ifi202, an interferon-inducible lupus susceptibility gene, through activation of JNK/c-Jun pathway. Immunol Lett (2008) 0.86
Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes. Am J Pathol (2003) 0.86
IFI16 in human prostate cancer. Mol Cancer Res (2007) 0.84
Inhibition of intracellular angiotensin II formation blocks high glucose effect on mesangial matrix. Regul Pept (2009) 0.83
Expression of murine Unc93b1 is up-regulated by interferon and estrogen signaling: implications for sex bias in the development of autoimmunity. Int Immunol (2013) 0.83
Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J Immunol (2011) 0.82
Comment on "Development of murine lupus involves the combined genetic contribution of the SLAM and Fc gamma R intervals within the Nba2 autoimmune susceptibility locus". J Immunol (2010) 0.82
Comment on "The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility". J Immunol (2011) 0.77